[Validity of Gynaegnost in the follow-up of patients treated for ovarian cancer].
Colorimetric assays of LDH on vaginal tampons were carried out in 45 women, following treatment for ovarian cancer, and apparently in complete remission. A small number of false positives seem to have been recorded and the authors plan to pursue this study in order to determine the exact value of this examination.
Cerejeira
L
L
Service de Gynécologie II de l'Instituto Portugues de Oncologia de Francisco Gentil, Centre de Porto, Portugal.
Pinto-Ferreira
M M
MM
Otilia-Bacelar
M O
MO
Moutinho
J
J
D000328:Adult; D014408:Biomarkers, Tumor / Q000032:analysis; D004796:Clinical Enzyme Tests / Q000295:instrumentation*; D003124:Colorimetry; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D052576:Menstrual Hygiene Products; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D010051:Ovarian Neoplasms / Q000175:diagnosis*; D014621:Vagina / Q000201:enzymology
D014408:Biomarkers, Tumor; D007770:L-Lactate Dehydrogenase
Validité du Gynaegnost dans le suivi de patientes traitées pour cancer de l'ovaire.